-
-
-
-
-
-
Executive committee
-
-
-
-
-
-
-
-
-
-
Chair of the Executive Committee / President of ENSAT
Cristina Ronchi MD, PhD, FRCP, DSc
Institute of Metabolism and Systems Research (IMSR)
University of Birmingham
& Centre for Endocrinology, Diabetes and Metabolism (CEDAM)
Birmingham Health Partners
Birmingham, UK
Dr Cristina L Ronchi is Reader in Endocrine Oncology at the Institute of Metabolism and Systems Research (University of Birmingham, UK). She is also Consultant Endocrinologist at the Queen Elizabeth Hospital Birmingham, where she serves as the Lead of the Adrenal Tumour Specialist Service. Her current research field focuses on the molecular pathogenesis of adrenocortical tumours and Cushing syndrome as well as novel prognostic markers for patients with adrenocortical cancer.
Dr Ronchi is a member of many national and international societies, is on the editorial board of several international journals and coordinated multiple studies on behalf of the ENS@T.
Period in office as NAPACA WG Head: 2021-2024
Period in office as President: 2025-2027
Treasurer and Head of the PPGL Working Group
Dr Judith FAVIER
Research Director, Head of the Genetics and Metabolism of Rare Cancers Laboratory, INSERM U970 – Paris-Cardiovascular Research Centre of the Georges Pompidou Hospital (HEGP), University Paris, Paris, France
Judith Favier was trained as a molecular and cellular biologist as a PhD at the Collège de France (Paris) and a post-doctoral fellow at the Montreal Heart Institute (Canada), during which she studied the role of HIF2a in angiogenesis. Since, her main research interest has been the study of the genetics and the biology of pheochromocytomas and paragangliomas with a particular focus on SDHB-mutated tumors. She holds a Research Director position in the French National Institute of Health and Medical Research (INSERM) and leads the team “Genetics and Metabolism of Rare Cancers” at the PARCC-HEGP. She is the Co-Chairman of the «Animals models» working group of the Pheochromocytoma Research Support Organization (PRESSOR) and was the previous co-chair of PRESSOR (2015-2018). She is an Associate Editor at the Endocrine-related Cancer journal.
Period in office as Head of PPGL WG and treasurer: 2021-2027
Secretary
Dr. Enzo Lalli
Research Director, Inserm
Head of the «Mechanisms of gene expression regulation in physiopathology» team
Institut de Pharmacologie Moléculaire et Cellulaire (IPMC) CNRS i
Valbonne (France)
Coordinator of the CNRS EXPOGEN-CANCER International Research Project. His research interests are focused on the development, function and pathology of the adrenal gland.
Period in office as secretary: 2023-2026
Michaela Luconi, PhD
Department of Experimental and Clinical Biomedical Science "Mario Serio"
University of Florence
P.zza S.Marco, 4
Florence, Italy
Matthias Kroiss, MD, PhD,
Professor in Endocrine Oncology
Ludwig-Maximilians-University of Munich | LMU ·
Department of Endocrinology and Diabetology
Munich, Germany
Period in office: 2023-2026
Heads of working groups
ACC Working Group
Massimo Terzolo, MD
Head of Department of Internal Medicine I
University of Torino
Regione Gonzole 10
Torino, Italy
Period in office: 2019-2025
see above under Secretary
NAPACA Working Group
Guido di Dalmazi, MD
Unit of Endocrinology and Diabetes Prevention and Care
Department of Medical and Surgical Sciences
Alma Mater Studiorum University of Bologna
IRCCS S. Orsola Policlinic
Bologna (Italy)
Guido Di Dalmazi is an Associate Professor in Endocrinology at the Division of Endocrinology and Prevention and Care of Diabetes in the Department of Medical and Surgical Sciences at the University of Bologna. He is the Director of the School of Specialization in Endocrinology of the University of Bologna. His research field focuses on adrenocortical tumors, with specific focus on hypercortisolism and adrenocortical cancer. Prof. Di Dalmazi is a member of several National and International Societies. He is coordinator of the Adrenal group of the Italian Society of Endocrinology and serves as Associate Editor for the Journal of Endocrinological investigation.
Period in office as Head of NAPACA WG: 2025-2027
APA Working Group
Peter Igaz, MD, MSc, PhD, DSc
Head of the Department of Endocrinology
Semmelweis University
Dept. of Endocrinology, Dept. of Internal Medicine and Oncology, ENETS center of excellence, ENSAT research center of excellence
Budapest, Hungary
Peter Igaz is full professor of internal medicine and endocrinology. He is currently the head of the Department of Endocrinology at the Department of Internal Medicine and Oncology, Semmelweis University. Between July 2016 and May 2020, he served as the director of the 2nd Department of Internal Medicine, Semmelweis University that under his leadership was awarded the Center of Excellence Title of the European Neuroendocrine Tumor Society in 2019. He is Co-Head of this ENETS Center of Excellence. In 2020, his research group was awarded the title of Research Center of Excellence by ENSAT. He has boarding exams in internal medicine, endocrinology, clinical genetics and clinical oncology. Beside his medical degree (MD), Dr. Igaz has degrees in biology (MSc, molecular biology) and laws (JD). He was awarded the PhD in 1999 and the Doctor of Sciences (DSc) by the Hungarian Academy of Sciences in 2013. His research focus includes the study of microRNAs, bioinformatics, adrenal tumors, hereditary endocrine neoplasia syndromes. Dr. Igaz has authored over 170 scientific papers and edited three books (Igaz P (Ed.): Circulating microRNAs in disease diagnostics and their potential biological relevance, Springer, 2015, Igaz P-Patócs A (Eds): Genetics of Endocrine Diseases and Syndromes, Springer, 2019, and Igaz P (Ed.): Practical Clinical Endocrinology, Springer, 2021). Moreover, he has written the popular science book of endocrinology: Hormonal Diseases, a Guide for the Layperson (Springer, 2024). He is an associate editor for the journal Endocrine Related Cancer.
Period in office as Head of APA WG: 2025-2027
KIDS Working Group
Christina Pamporaki, MD, PhD, PD habil
Department of Internal Medicine III,
University Hospital Carl Gustav Carus,
Dresden, Germany
Dr. Christina Pamporaki is a consultant endocrinologist and heads the Clinical Research Adrenal Unit at the University Hospital Carl Gustav Carus in Germany. She received her medical degree and completed her PhD Thesis at the University of Ioannina, School of Medicine, in Greece. She has acquired the specialty of “Internal Medicine, Endocrinology and Diabetes” and her Habilitation in “Internal Medicine and Endocrinology” at the Department of Internal Medicine III in the University Hospital Carl Gustav Carus, in Dresden, Germany. Dr. Pamporaki´s research interests focus on adrenal disorders, endocrine hypertension as well as on the application of laboratory analytics in clinical trials.
period in office: 2025-2028Chairs of local ENSAT scientific meetings committees
Ljiljana Marina, 24th ENS@T meeting 2025, Belgrade, Serbia. Period in office: 2024-2025
Duarte Pignatelli, 25th ENS@T meeting 2026, Porto, Portugal. Period in office: 2025-2026
---------------------------------------------------------------------------------------------------------------------------------------------
Pr Guillaume Assié
Endocrine department, Cochin hospital, APHP, Paris
Institut Cochin, Inserm CNRS, Université de Paris
Paris, France
Guillaume Assié is professor of Endocrinology in Université de Paris, working in the Endocrine department of Cochin hospital in Paris. He is specialized in general Endocrinology, mainly Cushing syndromes, adrenal tumors, and pituitary diseases.
His research activity is mainly focused on bioinformatics, mainly working on the genomic alterations of endocrine tumors, including adrenal tumors.
Period in office as treasurer: 2019-2021
Period in office as president: 2021-2024
Marcus Quinkler, MD
Berlin, Germany
Marcus Quinkler is Professor of Internal Medicine and Endocrinology and consultant in the endocrine outpatient center “Endocrinology in Charlottenburg” in Berlin, Germany.
His clinical research focus includes adrenal physiology and pathophysiology, endocrine hypertension, pituitary disease, and mineralocorticoid and glucocorticoid action.
Professor Quinkler is a member of the Endocrine Society, European Society of Endocrinology and European Network of the study of adrenal tumors. He was speaker of the German Adrenal section of the DGE (German Endocrine Society), and is associated faculty member of the Charité University Medicine Berlin, Germany.
Period in office as head of APA WG: 2021-2024
Martin Fassnacht, MD
Head of the Division of Endocrinology and Diabetes
Department of Internal Medicine I
University Hospital Würzburg
Oberdürrbacherstr. 6
Würzburg, Germany
Martin Fassnacht is Professor of Internal Medicine and Endocrinology at the University of Würzburg. He is head of the Division of Endocrinology and Diabetes at the University Hospital Würzburg. The main interest of his clinical and translational research group is endocrine tumors with a special focus on adrenal tumors. He run(s) several clinical trials for patients with adrenocortical carcinoma and malignant pheochromocytoma and his translational group is adrenocortical tumorigenesis and drug targets for adrenocortical carcinoma.
Period in office as president: 2016-2021
Period in office as ordinary member: 2021-2022
Henri Timmers, MD, PhD
Division of Endocrinology
Department of Internal Medicine
Radboud University Medical Centre
Geert Grooteplein Zuid 8
Radboud, The Netherlands
Henri Timmers (1971), M.D./Ph.D., is clinical endocrinologist and assistant professor at the Department of Medicine, section of Endocrinology, Radboud University Medical Centre, in Nijmegen, the Netherlands. He is head of the Radboud Adrenal Center and member of the steering committees of ENS@T and the international Pheochromocytoma and Paraganglioma Research Support Organization (PRESSOR). His principle clinical and scientific focus is on adrenal diseases, especially pheochromocytoma and paraganglioma.
Period in office as secretary: 2019-2022
Martin Reincke, MD
Medizinische Klinik und Poliklinik IV
University Hospital Munich
Ziemssenstr. 1
Munich, Germany
Martin Heinrich Reincke is the director of the Medizinische Klinik and Poliklinik IV, Ludwig-Maximilians University in Munich and Chair of the Department of Endocrinology and Diabetology..
His research focus includes adrenal physiology and pathophysiology, endocrine hypertension, pituitary disease, mineralocorticoid and glucocorticoid action and stress research. Professor Reincke is heading a research team specifically exploring the prevalence and relevance of mineralocorticoid excess in resistant hypertension on the epidemiological, clinical, genetic and molecular level.
Professor Reincke is a member of many national and international societies, including the Endocrine Society, European Society of Endocrinology and European Network of the study of adrenal tumors. He has served in the Executive Board of the German Endocrine Society and European Society of Endocrinology, is on the editorial board of several international journals, and has served as teaching dean of the faculty from 2006-2012.
Period in office as Head of APA WG: 2017-2021
Wiebke Arlt, MD, DSc., FRCP, FMedSci
Institute of Metabolism and Systems Research (IMSR)
University of Birmingham
& Centre for Endocrinology, Diabetes and Metabolism (CEDAM)
Birmingham Health Partners
Birmingham, UK
Professor Wiebke Arlt is William Withering Chair of Medicine and Director of the Institute of Metabolism and Systems Research at the University of Birmingham, UK. She leads a multi-disciplinary research group focussing on steroid endocrinology in the context of adrenal and gonadal disorders. She is a Consultant Endocrinologist at the Queen Elizabeth Hospital Birmingham, where she serves as the Lead of the Adrenal Tumour Specialist Service. Her main interests are adrenal incidentaloma, adrenocortical carcinoma and adrenal steroid excess syndromes.
Period in office as Head of NAPACA WG: 2017-2021
Mercedes Robledo, PhD
Hereditary Endocrine Cancer, Group Leader
Human Cancer Genetics Programme
Spanish National Cancer Centre (CNIO)
C/ Melchor Fernández Almagro 3
Madrid, Spain
Mercedes Robledo is the head of the Hereditary Endocrine Cancer Group, in the Human Genetics Cancer Program at the Spanish National Cancer Center (CNIO), Madrid, Spain. Her Group is interested in identifying high and low genetic risk factors involved in pheochromocytoma and thyroid cancer susceptibility. To this end, we analyse tumour samples and look for differences between genomic features according to the different individual genetic backgrounds. Such comprehensive characterisation allows us, not only to define diagnostic and prognostic markers associated with primary mutations, but also to pinpoint specific altered pathways that can lead to the identification of future therapeutic targets.
Period in office as Head of PPGL WG: 2017-2021
Endocrine Research
Unit
Medizinische Klinik
und Poliklinik IV
University Hospital Munich
Ziemssenstr. 1
Munich, Germany
Felix Beuschlein is Professor of Internal Medicine/Endocrinology, Head of the Endocrine Research Unit and runs the Endocrine Outpatient Clinic at the University Hospital in Munich. His main scientific interest pertain to all fields of adrenal research including adrenocortical carcinoma, primary aldosteronism, Cushing’s syndrome and pheochromocytoma. He has served as the chairman of ENSAT between 2008 and 2016 and has led an FP7 funded consortium on adrenal tumors (ENSAT-CANCER).
Period in office as president: 2016-2019Anne-Paule Gimenez-Roqueplo, MD, PhD
INSERM UMR 970
or/ Service de Génétique
Hôpital européen Georges Pompidou
rue Leblanc
Paris, France
Professor Anne-Paule Gimenez-Roqueplo (MD, specialized in Endocrinology, PhD in Genetics) is Full Professor in Genetics at Paris Descartes University. She is responsible of the Oncogenetic activity (molecular tests and multidisciplinary counsultation) in the Genetics department of Hôpital Européen Georges Pompidou (Paris, France). Her main interests are benign and malignant pheochromocytomas and paragangliomas (PPGL). She is the Director of an academic research team entitled “Pheochromocytomas and Paragangliomas, from Genetics to Molecular Targeted Therapies” within the INSERM Unit 970 at the Paris Cardiovascular Center at HEGP (PARCC@HEGP), Paris, France (http://parcc.inserm.fr/). She is the coordinator of PGL.R, the National French registry for SDHx-related paragangliomas.
Period in office as treasurer: 2013-2019
Tracy Ann Williams, BSc, PhD
Division of Internal Medicine and Hypertension
Department of Medical Sciences
University of Torino
Via Giuseppe Verdi 8
Torino, Italy
Dr. Williams heads the laboratory of genetics and molecular biology of hypertension in the Division of Internal Medicine and Hypertension, Department of Medical Sciences, University of Torino, Italy. She is visiting research scientist at the Medizinische Klinik and Poliklinik IV, Ludwig-Maximilians University in Munich. Her main interests are monogenic forms of hypertension and disorders of aldosterone production centering on aldosterone-producing adenomas.
Period in office as secretary: 2018-2019
Giuseppe Opocher, MD
Familial Cancer Clinic and Oncoendocrinology
Veneto Institute of Oncology
University of Padova
Via Gattamelata 64
Padova, Veneto, Italy
Period in office: 2014-2018
Henri Timmers, MD, PhD
Division of Endocrinology
Department of Internal Medicine
Radboud University Medical Centre
Geert Grooteplein Zuid 8
Radboud, The Netherlands
Henri Timmers (1971), M.D./Ph.D., is clinical endocrinologist and assistant professor at the Department of Medicine, section of Endocrinology, Radboud University Medical Centre, in Nijmegen, the Netherlands. He is head of the Radboud Adrenal Center and member of the steering committees of ENS@T and the international Pheochromocytoma and Paraganglioma Research Support Organization (PRESSOR). His principle clinical and scientific focus is on adrenal diseases, especially pheochromocytoma and paraganglioma.
Former Secretary of ENS@T. Period in office: 2011-2017
Jérôme Bertherat, MD, PhD
Institut National de la Santé et de la Recherche Médicale (INSERM)
Centre National de la Recherche Scientifique (CNRS)
Institut Cochin, Université Paris-Descartes
22, rue Mechain
Paris, France
Period in office: 2009-2016
Wiebke Arlt, Birmingham, UK. Period in office: 2009-2016
Massimo Terzolo, MD
Head of Department of Internal Medicine I
University of Torino
Regione Gonzole 10
Torino, Italy
Period in office: 2009-2014
Massimo Mannelli, Florence, Italy. Period in office: 2009-2011
Former chairs of local ENSAT scientific meetings committees
Rodrigo Toledo, 23rd ENS@T meeting 2024, Barcelona, Spain. Period in office: 2023-2024
Felix Beuschlein, 19th ENS@T eMeeting 2020 and 20th ENS@T eMeeting 2021. Period in office: 2018-2021
Aleksander Prejbisz, 21st ENS@T meeting 2022, Warsaw, Poland. Period in office: 2019-2022
Peyman Björklund, Uppsala, Sweden. Period in office 2018-2019.
Massimo Manelli
17th ENS@T meeting 2018, Florence, Italy.
Prof. Mannelli is Full Professor of Endocrinology in the Department of Experimental and Clinical Biomedical Sciences, University of Florence. He is the Director of the Clinical Endocrine Unit at the Azienda Ospedaliera-Universitaria Careggi, Florence. He has served as Director of the Post-graduate School of Endocrinology, University of Florence. His main research interests are pheochromocytoma/paragangliomas and adrenocortical cancer.He is coordinator of the Pheochromocytoma/Paraganglioma working group of the Italian Endocrine Society.
Period in office: 2017-2018
Felix Beuschlein, Munich, Germany. Period in office: 2009-2016
Founding Executive Committee Members (2002-2009)
Bruno Allolio, Würzburg, Germany
Xavier-Yves Bertagna, Paris, France
Massimo Manelli, Florence, Italy
Franco Mantero, Padua, Italy
Pierre-Francois Plouin, Paris, France
Paul M. Stewart, Leeds, UK
Martin Reincke, Munich, Germany